Circulating Microparticles from Patients with Septic Shock Exert Protective Role in Vascular Function

被引:144
作者
Mostefai, Hadj Ahmed [1 ,2 ]
Meziani, Ferhat [1 ,2 ,3 ]
Mastronardi, Maria Letizia [1 ,2 ]
Agouni, Abdelali [1 ,2 ]
Heymes, Christophe [4 ]
Sargentini, Cyrille [3 ]
Asfar, Pierre [3 ]
Martinez, Maria Carmen [1 ,2 ]
Andriantsitohaina, Ramaroson [1 ,2 ]
机构
[1] INSERM, U771, Fac Med, UMR 6214, F-49045 Angers, France
[2] Univ Angers, Angers, France
[3] CHU Angers, Serv Reanimat Med, Angers, France
[4] INSERM, U689, Paris, France
关键词
microvesicles; vasomotricity; cyclooxygenase; oxidative stress; sepsis;
D O I
10.1164/rccm.200712-1835OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Sepsis is an archetypal condition with molecular links between inflammation and coagulation. Both events can be orchestrated by the interaction between circulating and vascular cells that under activation release microparticles. Objectives: We characterized circulating microparticles from both nonseptic subjects and patients with septic shock and evaluated their contribution to vascular function. Methods: Circulating microparticles and their cell origin were measured in blood from 36 patients with septic shock and 18 nonseptic subjects by flow cytometry. Microparticles were then injected intravenously into mice and vascular reactivity was assessed in aorta. Expression and activity of enzymes involved in nitric oxide (NO) and cyclooxygenase metabolite production were analyzed. Measurements and Main Results: Circulating levels of microparticles and platelet- and enclothelial-derived microparticles were increased in septic patients. Surprisingly, septic microparticles enhanced the sensitivity of contraction of mouse aorta in response to serotonin. Interestingly, septic microparticles enhanced the contraction of aorta from lipopolysaccharide-treated mice. This effect was linked neither to increased calcium entry nor to Rho kinase inhibitor-sensitive mechanisms. In addition, the effect of septic microparticles was not modified either by NO-synthase or cyclooxygenase-2 inhibitors, and was not associated with NO or O(2)(-) overproduction. The nonselective cyclooxygenase-2 inhibitor indomethacin reduced, and the specific thromboxane A(2) antagonist SQ-29548 abolished, aortic contraction in mice treated with nonseptic and septic microparticles. The effect of septic microparticles was associated with increased thromboxane A(2) production, and was sensitive to a selective thromboxane A(2) antagonist. Conclusions: We provide evidence that increased circulating microparticles are protective against vascular hyporeactivity accounting for hypotension in patients with septic shock.
引用
收藏
页码:1148 / 1155
页数:8
相关论文
共 26 条
[1]   Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure [J].
Amabile, N ;
Guérin, AP ;
Leroyer, A ;
Mallat, Z ;
Nguyen, C ;
Boddaert, J ;
London, GM ;
Tedgui, A ;
Boulanger, CM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3381-3388
[2]   Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia [J].
Aras, O ;
Shet, A ;
Bach, RR ;
Hysjulien, JL ;
Slungaard, A ;
Hebbel, RP ;
Escolar, G ;
Jilma, B ;
Key, NS .
BLOOD, 2004, 103 (12) :4545-4553
[3]  
Assreuy Jamil, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P165
[4]   Severe sepsis and septic shock - Definitions, epidemiology, and clinical manifestations [J].
Balk, RA .
CRITICAL CARE CLINICS, 2000, 16 (02) :179-+
[5]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[6]   Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens [J].
Carmen Martinez, Maria ;
Larbret, Frederic ;
Zobairi, Fatiha ;
Coulombe, Josee ;
Debili, Najet ;
Vainchenker, William ;
Ruat, Martial ;
Freyssinet, Jean-Marie .
BLOOD, 2006, 108 (09) :3012-3020
[7]   The immuno-inflammatory cascade [J].
Galley, HF ;
Webster, NR .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (01) :11-16
[8]   NAD(P)H oxidase - Role in cardiovascular biology and disease [J].
Griendling, KK ;
Sorescu, D ;
Ushio-Fukai, M .
CIRCULATION RESEARCH, 2000, 86 (05) :494-501
[9]   Membrane microparticles:: Two sides of the coin [J].
Hugel, B ;
Carmen, M ;
Martínez, MC ;
Kunzelmann, C ;
Freyssinet, JM .
PHYSIOLOGY, 2005, 20 :22-27
[10]   EPR quantification of vascular nitric oxide production in genetically modified mouse models [J].
Khoo, JP ;
Alp, NJ ;
Bendall, JK ;
Kawashima, S ;
Yokoyama, M ;
Zhang, YH ;
Casadei, B ;
Channon, KM .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 10 (03) :156-161